09:39 AM EST - Correvio Pharma Corp : Announced that Glass, Lewis & Co., LLC, a leading independent proxy advisory firm, released a report recommending that Correvio shareholders vote in favor of the proposed plan of arrangement with ADVANZ PHARMA Corp. Limited. The Arrangement will be executed through a wholly-owned subsidiary of ADVANZ PHARMA. Correvio Pharma Corp
shares T.CORV are trading unchanged at $0.54.
